PHK
YARW

Point72 Hong Kong’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Point72 Hong Kong’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Hold
0
– -$1K – 2248
2020
Q4 		– Hold
0
– – – 1664
2020
Q3 		– Sell
-2
Closed -$14K – 1564
2020
Q2 		$14K Buy
+2
New +$13.5K ﹤0.01% 943

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Point72 Hong Kong's YARW Position: Q1 2021 in Review

Point72 Hong Kong held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Point72 Hong Kong first reported a position in YARW in Q2 2020 and has held it in 1 quarter since. The position peaked at $14K in Q2 2020. 81 funds tracked by Wall St. Rank hold YARW as of Q1 2021.

  • Point72 Hong Kong held 0 shares of Yarrow Bioscience, Inc. Common Stock worth $0 as of Q1 2021.
  • Point72 Hong Kong left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2021.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Point72 Hong Kong's portfolio in Q1 2021, its #2248 holding.
  • Point72 Hong Kong first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2020 and has held it in 1 quarter since.
  • Point72 Hong Kong's Yarrow Bioscience, Inc. Common Stock position peaked at $14K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2021.

Based on Point72 Hong Kong's 13F filing for Q1 2021, filed 17 May 2021.